Till startsida
To content Read more about how we use cookies on gu.se

Eivind Hovig (RR-HF)

Eivind Hovig, professor, Rikshospitalet,, Radiumhospitalet, Norway (RR-HF) holds positions as a group leader at the Institute for Cancer Research, and as section head at the Department of medical informatics at The Norwegian Radium Hospital. Professor Hovig received his PhD in molecular genetics in 1992.

He leads two research groups of students, post doctoral fellows and research associates whose work is focused on development and implementation of high-throughput techniques for genomics and clinical bioinformatics. His has extensive teaching experience at the University of Oslo the and currently supervises three masters students, five PhD students and two post docs.

He has authored some 70 articles in journals like Nature Genetics and Lancet, and received awards for scientific excellence as well as inventor prices. He is the leader of the FUGE functional genomics platform of bioinformatics in the Oslo region, member of the board of the national FUGE bioinformatics steering group, member of the FUGE national microarray steering group. He is chief scientific officer of the Norwegian based bioinformatics company, PubGene Inc., based on a patent application of Hovig, Jenssen et al. and also engaged in the formation of a company co-founded by Ideas ASA/GammaMedica and the Research Foundation of the Norwegian Radium Hospital, called Biomolex AS. This company is based on a patent application of Hovig, Skretting et al. He also serves as scientific adviser the Norwegian Lab-on-a-Chip company NorChip. Coholder of four US patents one Norwegian patent, and two patent pending applications.

Key publications

Jenssen TK, Laegreid A, Komorowski J, Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001; 28:21-8.

Page Manager: Johan Thompson|Last update: 11/20/2006

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?